Table 3.

Physicochemical characteristic of silver-based NPs.

Silver based inorganic NPs	REF	Abbreviation	Diameter (nm)	ζ - potential (mV)	Tested Uropathogens	Activity
							Silver nanoparticles	(Syed et al., 2009)	AgNps	9 – 24	NA	E. coli and S. aureus	Antibacterial
Silver boron nanoparticles	(El-Batal et al., 2019)	AgB NPs	25.46	NA	E. coli, S. aureus and C. albicans	Antibiofilm
Ag/ZnO nanoparticles	(Khoshkbejari et al., 2015)	Ag/ZnO NPs	12	NA	E. coli	Antibacterial
Silver nanoparticles-ampicilin	(Lopez-Carrizales et al., 2018)	AgNPs-AMP	4.01 ± 0.80	51.00 ± 20.20	E. faecium, S. aureus, A. baumannii, E. cloacae, three different isolates of E. coli, K. pneumoniae, M. morganii and P. aeruginosa	Antibacterial
Silver nanoparticles-amikacin	(Lopez-Carrizales et pal., 2018)	AgNPs-AMK	6.03 ± 0.87	-21.10 ± 4.63	E. faecium, S. aureus, A. baumannii, E. cloacae, three different isolates of E. coli, K. pneumoniae, M. morganii and P. aeruginosa	Antibacterial
Silver nanoparticles functionalized with L-fucose	(Bhargava et al., 2018)	FNPs	8 – 10	-17.7	P. aeruginosa	Antibacterial
Cationic silver nanoclusters coated with low molecular weight polyehylenimine	(Huma et al., 2018)	bPEI-Ag NCs	3	30	E. coli, P. aeruginosa, MRSA, E. cloacae, E. faecalis	Antibacterial